SCHEMBL1726415

SCHEMBL1726415

Oc1ccc(-c2cn3cc(I)ccc3n2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 6/20 0.66
NPC1 O15118 7/20 0.62
RAB9A P51151 6/20 0.62
KDM4E B2RXH2 4/20 0.62
GFER P55789 3/20 0.62
ALDH1A1 P00352 5/20 0.61
SMN1; SMN2 Q16637 3/20 0.61
POLB P06746 2/20 0.61
HPGD P15428 2/20 0.61
NFKB1 P19838 1/20 0.61
NFKB2 Q00653 1/20 0.61
RELA Q04206 1/20 0.61
RCE1 Q9Y256 1/20 0.61
PAX8 Q06710 2/20 0.53
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.53
MITF O75030 1/20 0.53
KDM5A P29375 1/20 0.53
KDM5C P41229 1/20 0.53
ALDH1A3 P47895 6/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1726261 0.98 NPC1 (0.65) APPNPC1RAB9AKDM4EGFER
SCHEMBL15177306 0.90 APP (0.73) APPNPC1RAB9AKDM4EALDH1A1
SCHEMBL2257095 0.86 APP (0.73) APPNPC1RAB9AKDM4EGFER
SCHEMBL24320031 0.85 NPC1 (0.74) APPNPC1RAB9AKDM4EGFER
SCHEMBL217156 0.83 RAB9A (0.75) APPNPC1RAB9AKDM4EALDH1A1
SCHEMBL26603206 0.83 APP (0.69) APPNPC1RAB9AKDM4EALDH1A1
SCHEMBL2904371 0.83 APP (0.66) APPNPC1RAB9AKDM4EGFER
SCHEMBL1985593 0.83 APP (0.66) APPNPC1RAB9AKDM4EALDH1A1
SCHEMBL6491308 0.83 ALDH1A3 (0.69) APPNPC1RAB9AKDM4EALDH1A1
SCHEMBL1727974 0.81 APP (0.52) APPNPC1RAB9AKDM4EGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2042501-B1 COMPOUND HAVING AFFINITY FOR AMYLOID NIHON MEDIPHYSICS CO LTD (JP) 2017-04-12 EP disclosed
US-8506930-B2 Compounds having affinity for amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2013-08-13 US disclosed
US-8506930-B2 Compounds having affinity for amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2013-08-13 US disclosed
US-8303935-B2 Alkoxy substituted imidazo[1,2-a]pyridines having affinity for amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2012-11-06 US disclosed
US-20120271053-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2012-10-25 US disclosed
US-20120271053-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2012-10-25 US disclosed
US-8277777-B2 Compound having affinity for amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2012-10-02 US disclosed
US-8277777-B2 Compound having affinity for amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2012-10-02 US disclosed
US-8207189-B2 Compound having affinity for amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2012-06-26 US disclosed
WO-2011029443-A8 DEVICE FOR A MULTIPLE SOCKET FOR RECEIVING PLUG CONNECTIONS HOHENADEL THORSTEN (DE) 2012-05-10 WO disclosed
US-20100092387-A1 Novel Compound Having Affinity For Amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2010-04-15 US disclosed
US-20100069640-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID NIHON MEDI-PHYSICS COL, LTD. (JP) 2010-03-18 US disclosed
US-20090252679-A1 Novel Compound Having Affinity for Amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2009-10-08 US disclosed
US-20090252680-A1 NOVEL COMPOUND WITH AFFINITY FOR AMYLOID NIHON- MEDI-PHYSICS CO., LTD (JP) 2009-10-08 US disclosed
US-20090252680-A1 NOVEL COMPOUND WITH AFFINITY FOR AMYLOID NIHON- MEDI-PHYSICS CO., LTD (JP) 2009-10-08 US disclosed
EP-2098523-A1 NOVEL COMPOUNDS WITH AFFINITY FOR AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2009-09-09 EP disclosed
EP-2098522-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2009-09-09 EP disclosed
EP-2042501-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2009-04-01 EP disclosed
EP-2022792-A1 NOVEL COMPOUND HAVING AFFINITY TO AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2009-02-11 EP disclosed
EP-2019103-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2009-01-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069640-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID APP, APBA1, C1QBP APP 1/4885NPC1 172/4885RAB9A 2084/4885
US-20100092387-A1 Novel Compound Having Affinity For Amyloid APP, SLC43A1, APBA1 APP 1/4885NPC1 138/4885RAB9A 1232/4885
US-20090252680-A1 NOVEL COMPOUND WITH AFFINITY FOR AMYLOID APBA1, APP, SLC7A1 APP 2/4885NPC1 222/4885RAB9A 1766/4885
US-20090252679-A1 Novel Compound Having Affinity for Amyloid APBA1, SAAL1, SLC43A1 APP 4/4885NPC1 412/4885RAB9A 1323/4885
US-20120271053-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID APBA1, SAAL1, SLC43A1 APP 4/4885NPC1 412/4885RAB9A 1323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.